202 related articles for article (PubMed ID: 20926832)
1. The Bayh-Dole Act turns 30.
Loise V; Stevens AJ
Sci Transl Med; 2010 Oct; 2(52):52cm27. PubMed ID: 20926832
[TBL] [Abstract][Full Text] [Related]
2. Patents, profits, and the American people--the Bayh-Dole Act of 1980.
Markel H
N Engl J Med; 2013 Aug; 369(9):794-6. PubMed ID: 23984726
[No Abstract] [Full Text] [Related]
3. Intellectual property. University licensing and the Bayh-Dole Act.
Thursby JG; Thursby MC
Science; 2003 Aug; 301(5636):1052. PubMed ID: 12933996
[No Abstract] [Full Text] [Related]
4. Technology transfer at US universities: seeking public benefit from the results of basic research.
Goodwin CD
Technol Health Care; 1996 Sep; 4(3):323-30. PubMed ID: 8931243
[TBL] [Abstract][Full Text] [Related]
5. Bayh-Dole: if we knew then what we know now.
Boettiger S; Bennett AB
Nat Biotechnol; 2006 Mar; 24(3):320-3. PubMed ID: 16525405
[No Abstract] [Full Text] [Related]
6. Can we expect to achieve anything from Indian Bayh Dole?
Janodia MD; Sreedhar D; Ligade VS; Udupa N
Indian J Med Res; 2009 Oct; 130(4):487. PubMed ID: 19942757
[No Abstract] [Full Text] [Related]
7. Bayh-Dole: almost 25.
Kennedy D
Science; 2005 Mar; 307(5714):1375. PubMed ID: 15746390
[No Abstract] [Full Text] [Related]
8. Columbia University's Axel patents: technology transfer and implications for the Bayh-Dole Act.
Colaianni A; Cook-Deegan R
Milbank Q; 2009 Sep; 87(3):683-715. PubMed ID: 19751286
[TBL] [Abstract][Full Text] [Related]
9. Why did universities start patenting? Institution-building and the road to the Bayh-Dole Act.
Berman EP
Soc Stud Sci; 2008 Dec; 38(6):835-71. PubMed ID: 19227798
[TBL] [Abstract][Full Text] [Related]
10. The Bayh-Dole Act at 40: Accomplishments, Challenges, and Possible Reforms.
Sarpatwari A; Kesselheim AS; Cook-Deegan R
J Health Polit Policy Law; 2022 Dec; 47(6):879-895. PubMed ID: 35877952
[TBL] [Abstract][Full Text] [Related]
11. Biobusiness on campus: commercialization of university-developed biomedical technologies.
Dueker KS
Food Drug Law J; 1997; 52(4):453-509. PubMed ID: 10346675
[No Abstract] [Full Text] [Related]
12. Drug prices: real problem, wrong solution.
Kennedy D
Science; 2001 Jun; 292(5523):1797. PubMed ID: 11397914
[No Abstract] [Full Text] [Related]
13. Patenting the PKU test--federally funded research and intellectual property.
Paul DB; Ankeny RA
N Engl J Med; 2013 Aug; 369(9):792-4. PubMed ID: 23984725
[No Abstract] [Full Text] [Related]
14. Don't feed the trolls.
Nature; 2014 Jun; 510(7503):7. PubMed ID: 24910865
[No Abstract] [Full Text] [Related]
15. Who owns federally funded research? The Supreme court and the Bayh-Dole act.
Kesselheim AS; Rajkumar R
N Engl J Med; 2011 Sep; 365(13):1167-9. PubMed ID: 21879888
[No Abstract] [Full Text] [Related]
16. Patents and innovation in cancer therapeutics: lessons from CellPro.
Bar-Shalom A; Cook-Deegan R
Milbank Q; 2002; 80(4):637-76, iii-iv. PubMed ID: 12532643
[TBL] [Abstract][Full Text] [Related]
17. March-in rights under the Bayh-Dole Act: the NIH's paper tiger?
O'Brien W
Seton Hall Law Rev; 2013 Nov; 43(4):1403-32. PubMed ID: 24308083
[No Abstract] [Full Text] [Related]
18. Research and the Bayh-Dole Act.
Reczek PR
Science; 2004 Jan; 303(5654):40. PubMed ID: 14704412
[No Abstract] [Full Text] [Related]
19. Is Bayh-Dole good for developing countries? Lessons from the US experience.
So AD; Sampat BN; Rai AK; Cook-Deegan R; Reichman JH; Weissman R; Kapczynski A
PLoS Biol; 2008 Oct; 6(10):e262. PubMed ID: 18959484
[TBL] [Abstract][Full Text] [Related]
20. A patent problem.
Nature; 2015 May; 521(7552):159-60. PubMed ID: 25993919
[No Abstract] [Full Text] [Related]
[Next] [New Search]
